Literature DB >> 10673207

Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant.

E Cutz1, S E Wert, L M Nogee, A M Moore.   

Abstract

We report a case of a full-term female infant who presented with severe respiratory distress shortly after birth and died at 23 d of age with unremitting respiratory failure. Infectious and other known causes of respiratory disease in this clinical setting were excluded. Examination of a lung biopsy showed abnormal lung parenchyma with features reminiscent of desquamative interstitial pneumonitis. Ultrastructural studies revealed that alveolar type II cells lacked cytoplasmic lamellar bodies, while other organelles appeared normal. Histochemical and immunohistochemical investigations indicated normal alveolar type II cell marker expression including surfactant proteins (SP-A, SP-B, pro-SP-B, and pro-SP-C). Mutations in the coding sequences of the SP-B gene were excluded as a cause of disease. This case appears to be a novel congenital defect affecting the pulmonary surfactant system. The cellular abnormality may involve the assembly of cytoplasmic lamellar bodies in alveolar type II cells-the principal storage site of pulmonary surfactant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673207     DOI: 10.1164/ajrccm.161.2.9905062

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Essential and mutually compensatory roles of {alpha}-mannosidase II and {alpha}-mannosidase IIx in N-glycan processing in vivo in mice.

Authors:  Tomoya O Akama; Hiroaki Nakagawa; Nyet Kui Wong; Mark Sutton-Smith; Anne Dell; Howard R Morris; Jun Nakayama; Shin-Ichiro Nishimura; Ashok Pai; Kelley W Moremen; Jamey D Marth; Michiko N Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  Diagnostic Pathology of Diffuse Lung Disease in Children.

Authors:  Megan K Dishop
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

Review 3.  Cellular mechanisms of alveolar pathology in childhood interstitial lung diseases: current insights from mouse genetics.

Authors:  Christin S Kuo; Tushar J Desai
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

4.  YAP regulates alveolar epithelial cell differentiation and AGER via NFIB/KLF5/NKX2-1.

Authors:  Jason J Gokey; John Snowball; Anusha Sridharan; Parvathi Sudha; Joseph A Kitzmiller; Yan Xu; Jeffrey A Whitsett
Journal:  iScience       Date:  2021-08-11

Review 5.  Genetic disorders of surfactant dysfunction.

Authors:  Susan E Wert; Jeffrey A Whitsett; Lawrence M Nogee
Journal:  Pediatr Dev Pathol       Date:  2009 Jul-Aug

Review 6.  [Interstitial pulmonary diseases].

Authors:  F Brasch
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

Review 7.  Exacerbations: etiology and pathophysiologic mechanisms.

Authors:  Jadwiga A Wedzicha
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

8.  In silico study reveals binding potential of rotenone at multiple sites of pulmonary surfactant proteins: A matter of concern.

Authors:  Prem Rajak; Sumedha Roy; Achintya Kumar Pal; Manas Paramanik; Moumita Dutta; Sayanti Podder; Saurabh Sarkar; Abhratanu Ganguly; Moutushi Mandi; Anik Dutta; Kanchana Das; Siddhartha Ghanty; Salma Khatun
Journal:  Curr Res Toxicol       Date:  2021-12-04

9.  Adhesion-GPCR Gpr116 (ADGRF5) expression inhibits renal acid secretion.

Authors:  Nathan A Zaidman; Viktor N Tomilin; Naghmeh Hassanzadeh Khayyat; Mahendra Damarla; Josephine Tidmore; Diane E Capen; Dennis Brown; Oleh M Pochynyuk; Jennifer L Pluznick
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-01       Impact factor: 11.205

10.  The common ABCA3E292V variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling.

Authors:  Yaniv Tomer; Jennifer Wambach; Lars Knudsen; Ming Zhao; Luis R Rodriguez; Aditi Murthy; Frances V White; Alessandro Venosa; Jeremy Katzen; Matthias Ochs; Aaron Hamvas; Michael F Beers; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-16       Impact factor: 6.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.